CAPLIN POINT Surges by 11%; BSE HEALTHCARE Index Down 0.2%
January 11, 2019 02:36 PM

CAPLIN POINT share price has zoomed 11% and is presently trading at Rs 423.

Meanwhile, the BSE HEALTHCARE Index is at 14,088 (down 0.2%).

Among the top Gainers in the BSE HEALTHCARE Index today is CAPLIN POINT (up 11.3%).

UNICHEM LAB and THYROCARE TECHNOLOGIES (down 0.1%) are among the top losers today.

Over the last one year, CAPLIN POINT has moved down from Rs 661 to Rs 423, registering a loss of Rs 239 (down 36.3%).

On the other hand, the BSE HEALTHCARE has moved down from 14,982 to 14,088, loss of 894 points (down 6.5%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were ABBOTT INDIA (up 52.9%), DIVIS LABORATORIES (up 39.7%) and PFIZER (up 35.0%).

What About the Benchmark Indices?

The BSE Sensex is at 36,214 (down 0.5%).

The top gainers among the BSE Sensex stocks today are ITC LTD (up 1.7%), VEDANTA LTD (up 0.8%) and ONGC (up 0.6%). Other gainers include KOTAK MAH. BANK (up 0.3%) and ASIAN PAINTS (up 0.1%). The most traded stocks in the BSE Sensex are ITC LTD and VEDANTA LTD.

In the meantime, NSE Nifty is at 10,850 (down 0.5%). ITC LTD (up 1.7%) is among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 34,433 to 36,214, registering a gain of 1,781 points (up 4.3%).

CAPLIN POINT Financial Update...

CAPLIN POINT net profit stood at Rs 111 million for the quarter ended March 2015, compared to a profit of Rs 105 million a year ago. Net Sales rose 4.5% to Rs 636.0 million during the period as against Rs 609.0 million in January-March 2014.

For the year ended June 2011, CAPLIN POINT reported 90.9% increase in net profit to Rs 63.0 million compared to net profit of Rs 33.0 million during FY10.

Revenue of the company grew 34.1% to Rs 779 million during FY11.

The current Price to earnings ratio of CAPLIN POINT, based on rolling 12 month earnings, stands at 17.2x.